InVivoMab anti-mouse CD3ε F(ab')2 fragment | Bio X Cell BE0001-1FAB product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Bio X Cell

product type :

antibody

product name :

InVivoMab anti-mouse CD3ε F(ab')2 fragment

catalog :

BE0001-1FAB

quantity :

5 mg

price :

500 USD

clonality :

monoclonal

host :

hamsters

conjugate :

nonconjugated

clone name :

145-2C11 f(ab')2 Fragments

reactivity :

mouse

citations: 5

Reference
Sarikonda G, Sachithanantham S, Miller J, Pagni P, Coppieters K, von Herrath M. The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice. J Autoimmun. 2015;59:61-6 pubmed publisher
Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, et al. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc Res. 2014;102:107-17 pubmed publisher
Shiheido H, Aoyama T, Takahashi H, Hanaoka K, Abe T, Nishida E, et al. Novel CD3-specific antibody induces immunosuppression via impaired phosphorylation of LAT and PLCγ1 following T-cell stimulation. Eur J Immunol. 2014;44:1770-80 pubmed publisher
Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, et al. CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. J Am Heart Assoc. 2014;3:e000719 pubmed publisher
Grant C, Moran-Paul C, Duclos S, Guberski D, Arreaza-Rubín G, Spain L. Testing agents for prevention or reversal of type 1 diabetes in rodents. PLoS ONE. 2013;8:e72989 pubmed publisher

product information

Catalog Number :

BE0001-1FAB

Product Name :

InVivoMab anti-mouse CD3ε F(ab')2 fragment

Host Species :

hamster

Clonality :

monoclonal

Product Type :

antibody fab fragment

Size :

5 mg

List Price :

800

Acedemic Discount Price :

500 USD

Clone :

145-2C11 f(ab')2 Fragments

Isotype :

IgG2b

Specificity :

mouse

Application Summary :

in vivo T cell depletion